MIA GALIOTO: Open Payments
NPI 1225011307 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$176 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $41 · 2025 $176
Food & beverage: $176
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $69 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Phadia US Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: FANAPT, Auvelity, INGREZZA, REXULTI, ImmunoCAP, Mirena.
Industry payments across IL — which companies pay providers there.
